Approval · Notice of Compliance 2016 · 1999
COUMADIN: Notice of Compliance 2016
Issued May 21, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2016
- Date
- May 21, 1999
- Company
- Dupont Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strengths
- Therapeutic class
- Anticoagulant
Products in this notice
Medicinal ingredients
- WARFARIN SODIUM 3 MG per TAB
- WARFARIN SODIUM 6 MG per TAB